Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Core earnings per share was $1.27, reflecting a sequential increase from Q1 2025. Core Return on Tangible Common Equity-- Core return on tangible common equity was 18.03%, an increase from Q1 2025.

The best place to start is to determine how the stock is valued, and one of the most popular and effective metrics to help make that judgment is earnings per share, known as EPS. "We use a wide ...

The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...

The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research ...

In a conference call, AMD CEO Lisa Su (pictured) admitted that the export controls have been problematic for the company. “AI business revenue declined year-over-year as U.S. export restrictions ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.